NGL Fine-Chem Limited (NGLFINE.BO)

INR 1132.25

(-5.0%)

Total Debt Summary of NGL Fine-Chem Limited

NGL Fine-Chem Limited's latest annual total debt in 2023 was 324.42 Million INR , up 6.44% from previous year.
NGL Fine-Chem Limited's latest quarterly total debt in 2023 FY was 324.42 Million INR , up 6.44% from previous quarter.
NGL Fine-Chem Limited reported annual total debt of 304.78 Million INR in 2022, up 1.59% from previous year.
NGL Fine-Chem Limited reported annual total debt of 300.01 Million INR in 2021, up 82.4% from previous year.
NGL Fine-Chem Limited reported quarterly total debt of 324.42 Million INR for 2023 FY, up 6.44% from previous quarter.
NGL Fine-Chem Limited reported quarterly total debt of 272.1 Million INR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of NGL Fine-Chem Limited (2023 - 2008)

Historical Annual Total Debt of NGL Fine-Chem Limited (2023 - 2008)

Year	Total Debt	Total Debt Growth
2023	324.42 Million INR	6.44%
2022	304.78 Million INR	1.59%
2021	300.01 Million INR	82.4%
2020	164.48 Million INR	-41.74%
2019	282.31 Million INR	3.94%
2018	271.62 Million INR	1.86%
2017	266.67 Million INR	16.63%
2016	228.65 Million INR	58.43%
2015	144.32 Million INR	29.31%
2014	111.61 Million INR	-33.1%
2013	166.85 Million INR	40.21%
2012	119 Million INR	36.01%
2011	87.49 Million INR	52.3%
2010	57.44 Million INR	13.78%
2009	50.49 Million INR	21.96%
2008	41.39 Million INR	0.0%

Year	Total Debt	Total Debt Growth
2023 Q3	- INR	-100.0%
2023 FY	324.42 Million INR	6.44%
2023 Q2	272.1 Million INR	0.0%
2023 Q1	- INR	-100.0%
2023 Q4	324.42 Million INR	0.0%
2022 FY	304.78 Million INR	1.59%
2022 Q2	267.29 Million INR	0.0%
2022 Q1	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q4	304.78 Million INR	0.0%
2021 Q2	192 Million INR	0.0%
2021 Q3	- INR	-100.0%
2021 Q4	300.01 Million INR	0.0%
2021 FY	300.01 Million INR	82.4%
2021 Q1	- INR	-100.0%
2020 Q2	244.52 Million INR	0.0%
2020 Q4	164.48 Million INR	0.0%
2020 FY	164.48 Million INR	-41.74%
2019 Q4	282.31 Million INR	0.0%
2019 FY	282.31 Million INR	3.94%
2019 Q2	241.71 Million INR	0.0%
2018 FY	271.62 Million INR	1.86%
2018 Q4	271.62 Million INR	0.0%
2018 Q2	261.28 Million INR	0.0%
2017 Q2	225.55 Million INR	0.0%
2017 Q4	266.67 Million INR	0.0%
2017 FY	266.67 Million INR	16.63%
2016 Q2	118.12 Million INR	0.0%
2016 FY	228.65 Million INR	58.43%
2016 Q4	246.42 Million INR	0.0%
2015 Q2	132.42 Million INR	0.0%
2015 Q4	127.53 Million INR	0.0%
2015 FY	144.32 Million INR	29.31%
2014 FY	111.61 Million INR	-33.1%
2014 Q4	111.61 Million INR	0.0%
2014 Q2	126.68 Million INR	0.0%
2013 Q4	166.85 Million INR	0.0%
2013 FY	166.85 Million INR	40.21%
2013 Q2	119.69 Million INR	0.0%
2012 Q4	119 Million INR	0.0%
2012 FY	119 Million INR	36.01%
2011 Q4	87.49 Million INR	0.0%
2011 FY	87.49 Million INR	52.3%
2010 FY	57.44 Million INR	13.78%
2009 FY	50.49 Million INR	21.96%
2008 FY	41.39 Million INR	0.0%
2008 Q4	41.39 Million INR	0.0%

Peer Total Debt Comparison of NGL Fine-Chem Limited

Name	Total Debt	Total Debt Difference
Abbott India Limited	832.3 Million INR	61.021%
Cipla Limited	5.59 Billion INR	94.201%
Gland Pharma Limited	3.72 Billion INR	91.283%
GlaxoSmithKline Pharmaceuticals Limited	186.65 Million INR	-73.814%
Kopran Limited	992.28 Million INR	67.305%
Marksans Pharma Limited	2.44 Billion INR	86.707%
Pfizer Limited	945.4 Million INR	65.684%
Sanofi India Limited	190 Million INR	-70.749%
SMS Pharmaceuticals Limited	2.8 Billion INR	88.445%